MedTrace Logo

Effects of Armolipid Plus on Cholesterol Levels and Endothelial Function

NCT00654459 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2008-04-16

No results posted yet for this study

Summary

Some nutraceuticals are often advised for their lipid lowering effects. Although many clinical trials have been conducted to assess their efficacy many doubts remain whether they could be considered an effective alternative to statins therapy.

The aim of this study was to evaluate the lipid lowering effects and the improvement of endothelial dysfunction in patients with hyperlipidemia, treated with a nutraceutical product (Armolipid Plus)

Conditions

Interventions

DIETARY_SUPPLEMENT

Mixture of Berberine, Policosanol, Red Yeast, Placebo

A tablet one a day for 6 weeks

Sponsors & Collaborators

  • Rottapharm

    collaborator INDUSTRY

  • Federico II University

    lead OTHER

Principal Investigators

  • Serafino Fazio, MD · Federico II University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2008-01-31
Completion
2008-04-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00654459 on ClinicalTrials.gov